BACKGROUND: Survivorship care plans (SCPs) and care-planning sessions have been recommended for over a decade, yet evidence for their benefit remains mixed. In a randomized trial, changes in survivor knowledge and satisfaction before and after the receipt of an SCP were assessed. METHODS: Patients with breast cancer who had completed curative-intent treatment were randomized to immediate versus delayed receipt of an individualized SCP. All participants completed the modified Wisconsin Survey of Cancer Diagnosis and Management in Breast Cancer and the Preparing for Life As a New Survivor survey to assess individual knowledge about cancer diagnosis, treatment, side effects, and follow-up as well as satisfaction with communication and care coordination. Surveys were completed at baseline, at 4 weeks (before delayed receipt), and again at 12 weeks (after all participants had received SCPs); the primary outcome was change in knowledge at 4 weeks. RESULTS: In total, 127 eligible women were randomized. An improvement in individual knowledge was observed between baseline and week 12 for both arms combined (+1.6; 95% confidence interval, 0.9-2.3; P < .001). There was no statistically significant difference in the change in knowledge from baseline through week 4 between the arms. No significant change occurred for satisfaction scores over time. CONCLUSIONS: This randomized trial of immediate versus delayed SCP receipt demonstrated a small improvement (4%) in survivor knowledge. However, this improvement did not appear to be related to SCP provision. The authors hypothesized that the improvement was because of repeated administration of the knowledge survey. If improved survivor knowledge is a goal, then strategies beyond the 1-time provision and review of an SCP should be explored.
INTRODUCTION
The number of cancer survivors is rising rapidly because of improvements in detection and therapy, and it is predicted that there will be nearly 26.1 million cancer survivors by 2040, most of whom will live ≥5 years after cancer diagnosis. 1, 2 It has been demonstrated that inadequate coordination after the completion of active cancer treatment results in a failure to provide necessary surveillance as well as increased costs because of duplicative care. [3] [4] [5] The Institute of Medicine recommends providing every survivor with a personalized survivorship care plan (SCP) at the end of cancer treatment. 6 SCPs have the potential to improve communication care coordination, with an end goal of improving survivor health outcomes. 6 National accreditation guidelines mandate that a significant percentage of survivors receive both an SCP and a care-planning visit. 7 Efforts have been made to understand the impact of SCPs, although relatively few studies have been randomized. [8] [9] [10] [11] [12] [13] Survivor health outcomes could be improved by increasing survivor knowledge of treatment details, planned
Cancer March 15, 2019 follow-up care, and future side effects, which are often poor. [14] [15] [16] [17] For instance, if a patient with lymphoma receives radiation to her chest wall at age 20 years, then any of the following knowledge conditions can enhance the delivery of needed care in the survivorship phase if the survivor knows: 1) that she received radiation, 2) that this radiation increases her risk of breast cancer, or 3) that she should be screened with both mammograms and magnetic resonance imaging (MRI) because of her increased risk. Knowledge alone is not sufficient, because the survivor also must be engaged and activated to use this knowledge along with having access to health care providers. The patient's health care providers also may need increased knowledge of their own, such as an awareness that chest-wall radiation increases the risk of breast cancer or the appropriate screening to implement. If accurate and thorough SCPs are provided, then they may serve to rectify these knowledge gaps for survivors and primary care providers.
The literature suggests improvements in survivor knowledge after receipt of a treatment summary, SCP, or care-planning visit, but these studies have been limited by small size 14 or lack of a control group. 15, 18, 19 Without a control group, it is difficult to separate change driven by increasing familiarity, because surveys are repeated or participants seek out knowledge in response to a survey question rather than learning from the SCP or care-planning visit. To test our hypothesis that SCPs improve survivor knowledge regarding the details of cancer diagnosis, treatment, side effects, and follow-up, we conducted a randomized clinical trial to determine the impact of SCP documents. The primary endpoint was change in survivor knowledge. [20] [21] [22] Secondary endpoints included the impact of SCPs on survivor satisfaction with communication and knowledge as well as survivor use and feedback on SCP content, delivery, and timing.
MATERIALS AND METHODS

Participant Population
Patients with stage 0 through III breast cancer who were within 2 years of active primary treatment were eligible and were recruited from 2 cancer centers (this included a tertiary referral center with cancer subspecialists serving a mixed urban and rural population and a communitybased practice with general oncologists serving a largely rural population.) Active treatment included curativeintent surgery, chemotherapy, or radiation, but not ongoing HER2-targeted or endocrine therapies. Patients were excluded if they: 1) had metastatic disease, 2) were unable to complete the surveys electronically, or 3) had already received an SCP.
Surveys
The Wisconsin Survey of Cancer Diagnosis and Management in Breast Cancer (WiSDOM-B) 14 was modified to allow the inclusion of bilateral or locally recurrent breast cancer. The 23-item survey is scored based on a comparison of survivor responses to information abstracted from the survivor's medical record and concentrates on cancer diagnosis, treatment, and follow-up questions with distinct answers. Participants also completed a modified Preparing for Life As a New Survivor (PLANS) questionnaire, 23 which assesses satisfaction with an individual's knowledge in 3 areas (diagnosis, treatment and adverse effects, and follow-up and plan of care) as well as health care team communication regarding these areas. Both surveys have been used previously in survivorship research. 12, 14 Figure 1 includes the study schema. The surveys (WiSDOM-B plus PLANS) were completed online at baseline and at weeks 4 and 12. Participants also completed a final feedback survey about SCP content, methods of receiving SCPs, and any difficulties encountered accessing SCPs. All survey questions are provided in the Supporting Materials.
Timeline
Each enrolled participant received a baseline survey, as indicated in Figure 1 . Participants who completed the baseline survey were randomized to immediate receipt of an individualized SCP versus delayed receipt. Four weeks after baseline, all participants were surveyed again, and participants in the delayed-receipt arm were provided with access to an individualized SCP after completing the surveys. Twelve weeks after baseline, all participants were surveyed a third time. Participants who developed recurrent or metastatic disease on study did not receive additional surveys. Participants who failed to complete the 4-week and/or 12-week surveys still were invited to take subsequent surveys. Participants were compensated upon completion of the feedback survey.
SCP Creation
Individual SCPs were prepared according to the center's standard of care at the time, as previously described in detail. 21 SCP content included 4 main sections: "Guide" (describing the purpose and content of SCPs), "Treatment Summary," "Follow-Up Plan," and "Glossary of Terms" (defining terms such as grade, receptors, etc).
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SCP Delivery
At study development, no guidelines required a careplanning visit (the Commission on Cancer has since issued guidelines regarding such visits). 7 Thus, 2 cohorts were designated with assignment based on participant interest and/or availability of resources to provide a careplanning visit. Cohort 1 received only SCP documents, whereas cohort 2 received an SCP document with an intended care-planning visit. In-person care-planning visits were encouraged. Assignment to the cohorts was not random and was not distributed equally between the cancer centers but, rather, was based on the resources available for care-planning visits. At study inception, cancer center 1 did not have resources for visits. Cancer center 2 did have those resources and offered them as the standard of care. By the time resources became available at cancer center 1, cohort 1 had fully accrued, and all patients in cohort 2 approached regarding the study were offered a care-planning visit. Care-planning visits followed the standard of care at each cancer center but included a review of the SCP document when they occurred. Participants who had internet access received access to their SCPs online using password-protected accounts on a secure website to track and collect data on plan use (logins, frequency of use, visits to SCP sections). SCP content was uploaded to the 4 sections (Guide, Treatment Summary, Follow-Up Plan, and Glossary of Terms). Participants without internet access received paper SCPs. At study completion, all study accounts were inactivated (participants were provided their SCPs via usual clinical means at this point). Screen shots of the website content are provided at the end of the Supporting Materials. 
Analysis Plan
The prespecified primary hypothesis test was a comparison of changes in WiSDOM-B scores from baseline to week 4 between the immediate-receipt and delayedreceipt groups, which were tested separately for each site at α = .025 (for an overall α = .05). A prespecified secondary hypothesis test for a nonzero increase in the knowledge score from baseline to week 12 in all participants was tested separately at each site, again, at α = .025. Under design assumptions, 52 participants (26 per group) for each site were expected to provide 90% power to detect a group difference in the WiSDOM-B raw score of a 4-point change (10% normalized) in the WiSDOM-B score after 4 weeks (primary) and >95% power to detect an overall increase in the WiSDOM-B raw score of 2.5 points (10% normalized) across all participants after 12 weeks (secondary). To allow for roughly 20% attrition, we recruited 64 participants in each cohort (total, 128 participants). Categorical data were summarized using counts and percentages, and means or medians and ranges with standard deviations were used to summarize continuous data. WiSDOM-B scores were calculated using a scoring algorithm that compared survey responses with information from electronic medical records to calculate a total score ranging from 0 to 40 points, with 6 subscores. Normalized scores were calculated by transforming them to a scale from 0% to 100%, and changes in scores from baseline were summarized as means with 95% confidence intervals.
The total PLANS score was calculated whenever at least 8 of 15 questions were answered as the prorated total of the nonmissing responses (from 1 [very unsatisfied] to 4 [very satisfied]), for a possible score ranging from 15 to 60. Normalized scores were calculated by transforming them to a scale from 0% to 100%. Normalized PLANS subscores were calculated on a similar basis when at least 2 of 3 subscore questions had been answered.
For both WiSDOM-B and PLANS scores, hypothesis tests for a nonzero change from baseline and for differences in change between randomized groups/ nonrandomized cohorts were calculated using 1-group (paired pre/post) and 2-group t tests, respectively. For SCP feedback, differences according to information category were assessed using a 2-factor analysis of variance (with participant and category as the 2 factors).
RESULTS
Demographics and Characteristics
The 2 centers enrolled 128 women with breast cancer between November 2013 to December 2014 (85 women at center 1 and 43 women at center 2). Of 127 eligible enrolled patients, 121 (95%) completed a baseline survey and were randomized, and 116 (91%) had at least 1 postbaseline survey available for analysis. See Table 1 for demographic data.
Receipt of a Care-Planning Visit
At center 1, 64 of 85 participants (75%) received only an SCP, whereas 21 (25%) received an SCP and careplanning visit. At center 2, care-planning visits could not be confirmed by chart review, because the staff did not document care-planning visits but only the creation of an SCP. Although care-planning visits were part of the workflow of care-plan delivery at cancer center 2, specific documentation of the visit, the visit type, and any topics covered were unavailable. On the basis of discussions with the survivorship team at cancer center 2, it was possible for patients to have an SCP created and delivered without a visit if no face-to-face or telephone encounter could be arranged. Thus, the 43 patients who were recruited from cancer center 2 were classified as having "unconfirmed care-planning visits," although, in all likelihood, most of the participants for whom an SCP was created also would have received a care-planning visit.
SCP Use by Participants
Most participants (n = 121; 95%) received access to an individualized SCP over the website (participants who received paper SCPs are not included in the usage analyses). Most participants (90 of 121 patients; 74%) accessed the website to review their SCP, usually within 2 days of receiving access (70 of 90 patients; 79%). The Treatment Summary was the most frequently visited section (158 visits by 69 participants), followed by the Follow-Up Plan (124 visits by 65 participants), the Guide (113 visits by 62 participants), and the Glossary (46 visits by 31 participants). Table 1 indicates that WiSDOM-B baseline scores ranged widely. Figure 2 illustrates changes in the mean WiSDOM-B score for the immediate-receipt arm ( Fig. 2A) versus the delayed-receipt arm (Fig. 2B ) from baseline through week 12. Overall, a modest improvement in individual knowledge, as measured by overall scores, was observed between baseline and week 12 for both arms combined (raw score, +1.6 [95% confidence interval, 0.9-2.3]; normalized score, +4.0 [95% confidence interval, 2.3-5.6]; P < .001). However, there was no statistically significant difference in the change in knowledge from baseline through week 4 between the Cancer March 15, 2019 Cancer March 15, 2019 immediate-receipt arm versus the delayed-receipt arm as illustrated in Figure 2 . This suggests that the improvement was not because of SCP receipt. The results also did not differ significantly between the centers or by care-planning visit status (compared with those who had confirmed visits).
Knowledge
Satisfaction
For the 116 participants who had evaluable baseline PLANS scores, total scores exhibited the full possible range from 15 to 60 points (normalized to 0%-100%), with mean ± standard deviation (SD) scores of 49.6 ± 10.1 (76.8% ± 22.5%). The results did not differ significantly between the centers or according to the receipt of a careplanning visit and thus are presented in aggregate for all participants.
At baseline, the mean ± SD scores for satisfaction with participants' own knowledge of diagnosis, treatment, and follow-up were 3.4 ± 0.77, 3.2 ± 0.83, and 3.4 ± 0.78, respectively, on scales from 1 (strongly disagree) to 4 (strongly agree with the statement "I am satisfied with what I currently know about…"). The mean ± SD scores for satisfaction with the cancer team's communication to the patient regarding diagnosis, treatment, and follow-up were 3.5 ± 0.73, 3.3 ± 0.82, and 3.4 ± 0.80, respectively. There was no evidence of a change in the total PLANS score from baseline to week 4 (P = .52) or week 12 (P = .49). However, post-hoc analyses of subscore changes from baseline to postbaseline time points indicated small decreases in satisfaction with communication from cancer care team to patient (mean change, −0.09; P = .04), participant's own knowledge (mean change, −0.11; P = .02), and primary care provider knowledge (mean change, −0.15; P = .003).
Feedback Regarding SCPs
Participants (n = 116) were invited to provide feedback regarding the content, method of delivery, and timing of SCP delivery, and 85% (n = 99) provided at least partial feedback responses. Participants rated the mean overall usefulness and ease of understanding of the SCP: The mean ± SD usefulness score was 8.7 ± 1.8 on a scale from 1 (not at all useful) to 10 (very useful), and the mean ± SD understandability score was 8.6 ± 1.7 on a scale from 1 (very hard to understand) to 10 (very easy to understand). Participants rated both the method and the timing of SCP distribution on a 10-point scale from 1 (worst) to 10 (best). There were significant differences in the ratings of distribution methods (P < .001), with the most preferred distribution methods being "a letter sent to your home" (mean score, 8.5) or "a printed document at a clinical visit" (mean score, 7.8) versus patient portal (mean score, 7.2) or email (mean score, 6.9). There also were significant differences for timing (P < .001), and the most preferred timing was "right after finishing treatments" (mean score, 8.3) or "at least a few months after finishing treatment" (mean score, 6.9) compared with 1 or 2 years (mean score, 3.7) or >2 years (mean score, 3.1) after finishing treatment or when discharged from cancer follow-up (mean score, 4.3).
DISCUSSION
The objective of this multisite clinical trial was to determine the impact of SCPs using a design that randomized survivors to immediate versus delayed receipt. Given the stated intent of providing SCPs and care-planning visits, the primary endpoint assessed was change in survivor knowledge regarding the details of cancer diagnosis, treatment, and side effects. Important secondary endpoints included change in survivor satisfaction with communication and knowledge. Finally, we also sought to quantify survivor use of SCPs and feedback on SCP content, delivery, and timing to elucidate the results of any change in knowledge or satisfaction. Our study is unique in assessing the impact of SCPs on survivor knowledge of diagnosis, treatment, side effects, and follow-up. At baseline, the population was generally well informed (76.8% of answers were correct). Over time, we observed that the knowledge of our survivors increased slightly (4%), whereas their satisfaction with their own knowledge decreased, irrespective of care-planning visit participation.
Several randomized clinical trials with various endpoints have now been conducted to understand the impact of SCPs. [8] [9] [10] [11] [12] [13] 24, 25 Defining the correct metrics to measure impact has proven challenging. 26 SCPs typically contain a summary of diagnosis and treatment and are specifically required to inform survivors with regard to future follow-up, recommended screening, and chronic or future side effects. Thus the assumption that SCPs would act to improve survivor knowledge on these topics is an eminently reasonable one that underlies the intent of providing them. Although improving knowledge alone is not sufficient to improve care coordination, it is a necessary component. To date, no randomized controlled study has examined whether SCPs have an impact on survivor knowledge, although 2 studies 15, 19 have demonstrated improvements in assessed
Cancer March 15, 2019 knowledge using surveys before and after SCP receipt. Although we also demonstrated an improvement in survivor knowledge, this change was likely unrelated to SCP provision. Improvement was not apparent until week 12, but the intervention arm had received SCPs by week 4. If the knowledge change was because of the SCPs, then the intervention arm should have demonstrated an improvement at week 4. We suspect that much of the improvement was the result of survivors seeking out information in response to their own uncertainty with regard to the correct survey answers. Although survivors might have sought those answers from an SCP, our usage data suggest that SCPs were accessed only once or twice. The small improvement in knowledge, which was approximately equivalent to answering 1 additional question correctly, also needs to be weighed against the effort involved in preparing, creating, and providing SCPs as well as tracking their provision. Finally, the provision of SCPs and assessing knowledge were associated with declines in survivor satisfaction with their care teams. We hypothesize that satisfaction declined as each survivor's attention was repeatedly drawn to knowledge gaps. This suggests that there may be potentially harmful consequences of SCP provision, as noted by others.
13,25
The current study has several key strengths, including high retention and completion rates. A key strength is the randomized and repeated assessment of SCP impact, rather than simple pre-SCP and post-SCP assessments. The repeated assessment was intended to allow us to capture improvements in the delayed-receipt arm after SCP provision, whereas the randomization allowed us account for changes in knowledge that were driven largely by repeated surveys (as appears to have occurred). Additional strengths include enrollment and provision of SCPs across more than 1 site and the pragmatic use of different SCP templates and visit types. This ensured that any impact observed did not depend on a particular template or visit type. A potential weakness includes the relatively small number of confirmed care-planning visits: cancer center 1 accounts for all 21 confirmed visits. However, this is because of specific differences in documentation of the visit and the SCP document. At cancer center 2, care-planning visits were considered the standard of care. SCP documents typically were provided within the context of telephone calls and face-to-face visits, but no specific documentation was used to confirm that a care-planning visit was conducted separate from the creation of an SCP. Other potential weaknesses include a relatively short time frame for assessment (12 weeks) and a population comprised of largely white (98.4%), female breast cancer survivors. Thus, our results might not apply over a longer timeframe or in a more diverse population. An additional weakness is that some survivors were more than 1-year post-diagnosis, which is later than the usual time recommended for SCP receipt according to guidelines. However, exploratory analyses suggest that the outcomes did not differ significantly by time since diagnosis. Moreover, little is known about the optimal timing for SCP delivery. 27, 28 Survivors in this study preferred earlier delivery of SCPs compared with later delivery. A final potential weakness is that we did not examine outcomes beyond changes in survivor knowledge and satisfaction. Additional outcomes of value might have included examining whether SCP recommendations are subsequently acted on as part of ongoing care. 29, 30 This was precluded by our study's short timeframe. However, survey questions included knowledge of upcoming care (eg, "Will you need a mammogram in the next 12 months?"), and such knowledge would be a prerequisite to survivor action (eg, the survivor cannot self-advocate for a screening test if she is unaware that it is recommended).
In summary, this randomized trial of immediate versus delayed receipt of SCPs demonstrates a relatively modest improvement in survivor knowledge in both groups at week 12, but not at the primary endpoint of 4 weeks. The improvement at 12 weeks appeared to be related to repeated administration of the knowledge survey rather than receipt of the SCP. The current "1-size-fits-all" approach to SCP provision may not benefit all survivors (those who already are well informed or for whom reviewing the information is particularly distressing). Moreover, attempts to improve survivor knowledge may need to examine strategies beyond a 1-time receipt of SCPs or care-planning visit. Possible options for improving knowledge, and even potentially for improving patient engagement, may include small, targeted pushes of key information, "test-your-knowledge" surveys, and/ or reviews in video or group sessions. Further research into the best strategies for improving survivor knowledge is warranted.
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